After a recent study showed that chronic lymphocytic leukemia patients who received ibrutinib as a frontline treatment had a 7% death rate, a new study offers a clearer picture on the reasons for the deaths.

Kimryn Rathmell, MD, PhD, director of the Division of Hematology and Oncology, received an award that honors women who embody the achievement, vision and inspiration of the founder of a local distillery.

James Dewar and colleagues have identified a role for the enzyme topoisomerase II in reducing replication errors during the final stage of DNA synthesis.

Vanderbilt researchers have uncovered another piece in the puzzle of how cells divide — a process that goes awry in cancer cells.

The Nashville Predators hockey team, longtime supporters of Monroe Carell Jr. Children’s Hospital at Vanderbilt and its programs, presented the hospital with the proceeds raised throughout the year from the team’s 365 Pediatric Cancer Fund.

Christina Bailey, MD, MSCI, assistant professor of Surgery, has been named the new program director of the general surgery residency training program in the Department of Surgery, Section of Surgical Sciences.

New research findings provide insight into the detrimental events that develop in response to H. pylori infection.

VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.

Jeffrey Rathmell, PhD, is a 2019 recipient of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity.

Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, was recruited to VUMC from The University of Texas MD Anderson Cancer Center in Houston.